RegenX Science
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
RegenX Science is a biotechnology company that develops a proprietary regenerative biomaterial for wound healing and tissue regeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RegenX Science Comparables
Compare RegenX Science with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ECM Therapeutics, Inc. | 85% | |
| Conexeu Sciences Inc. | 83% | |
| Solventum Corp. | 79% | |
RegenX Science Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Jun 19, 2026
Monthly visitors increased 90% MoM.
RegenX Science Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RegenX Science's valuation, stock price, and market status.